Dose-Escalation and Dose-Expansion Study of ZX-101A in Patients With Relapsed/Resistant or Refractory Advanced Hematologic Malignancies
Clinical trial NCT04504708 · TERMINATED
Trial details
- NCT number
- NCT04504708
- Sponsor
- Hangzhou Zenshine Pharmaceuticals Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-17
- Primary completion
- 2022-07-08
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.